Prevalence Rates of Abdominal Obesity, High Waist-to-Height Ratio and Excess Adiposity, and Their Associated Cardio-Kidney-Metabolic Factors: SIMETAP-AO Study
Open Access
- 19 November 2024
- Vol. 16 (22) , 3948
Abstract
Background/objective: In addition to obesity, adiposity and abdominal obesity (AO) are parameters included in the cardiovascular–kidney–metabolic (CKM) syndrome. However, their prevalence and association with the other CKM factors have been less studied. Our study aimed to determine the prevalence rates of AO, high waist-to-height ratio (WtHR), and excess adiposity (EA), and to compare their associations with CKM factors. Methods: A cross-sectional observational study was conducted with a random population-based sample of 6,588 study subjects between 18 and 102 years of age. Crude and sex- and age-adjusted prevalence rates of AO, high-WtHR, and EA were calculated, and their associations with CKM variables were assessed by bivariate and multivariate analyses. Results: The adjusted prevalence rates for AO, high-WtHR, and EA were 39.6% (33.6% in men; 44.9% in women), 30.6% (31.1% in men; 30.6% in women), and 65.6% (65.6% in men; 65.3% in women), respectively, and they increased with age. The main independent factors associated with AO, high-WtHR, and EA were hypertension, diabetes, prediabetes, low HDL-C, hypercholesterolaemia, hypertriglyceridemia, physical inactivity, hyperuricemia, and chronic kidney disease. Conclusions: Two-thirds of the adult population have EA, one-third have AO, and one-third have high-WtHR. These findings support that the other factors of CKM syndrome, in addition to hyperuricemia and physical inactivity, show an independent association with these adiposity-related variables.Keywords
Funding Information
- SIMETAP study (05/2010RS)
This publication has 68 references indexed in Scilit:
- Pathophysiology of obesity and its associated diseasesActa Pharmaceutica Sinica B, 2023
- Prevalence rates of overweight and obesity and their associations with cardiometabolic and renal factors. SIMETAP-OB studyClínica e Investigación en Arteriosclerosis (English Edition), 2022
- Tasas de prevalencia de enfermedad renal crónica y su asociación con factores cardiometabólicos y enfermedades cardiovasculares. Estudio SIMETAP-ERCClínica e Investigación en Arteriosclerosis, 2022
- Obesity and chronic kidney disease: A current reviewObesity Science & Practice, 2022
- Prevalencia de prediabetes y asociación con factores cardiometabólicos y renales. Estudio SIMETAP-PREDClínica e Investigación en Arteriosclerosis, 2022
- Standardized Definitions for Evaluation of Heart Failure Therapies: Scientific Expert Panel From the Heart Failure Collaboratory and Academic Research ConsortiumJACC: Heart Failure, 2020
- Population and methodology of the SIMETAP study: Prevalence of cardiovascular risk factors, cardiovascular diseases, and related metabolic diseasesClínica e Investigación en Arteriosclerosis (English Edition), 2018
- Relationships between body roundness with body fat and visceral adipose tissue emerging from a new geometrical modelObesity, 2013
- 2012 American College of Rheumatology guidelines for management of gout. Part 1: Systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemiaArthritis Care & Research, 2012
- Indices of abdominal obesity are better discriminators of cardiovascular risk factors than BMI: a meta-analysisJournal of Clinical Epidemiology, 2008